Researchers identify enzyme that suppresses immune system in breast cancer

by Duke University Medical CenterThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by T

Updated on: June 04,2024

Researchers identify enzyme that suppresses immune system in breast cancer

by Duke University Medical CenterThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by T

Updated on:June 04,2024

Skin cancer-related mutations higher in the UK than Singapore, new study shows

by Wellcome Trust Sanger InstituteA representation of protein-altering mutations in 1 square centimeter of skin from donors of the UK and Singapore. The UK square contains many more circles. Cred

Updated on: February 23,2024

Skin cancer-related mutations higher in the UK than Singapore, new study shows

by Wellcome Trust Sanger InstituteA representation of protein-altering mutations in 1 square centimeter of skin from donors of the UK and Singapore. The UK square contains many more circles. Cred

Updated on:February 23,2024

Study reveals persistent cancer disparities in Appalachian Kentucky

by Elizabeth Chapin,University of KentuckyCredit: Pixabay/CC0 Public DomainA recent University of Kentucky Markey Cancer Center study published inThe Journal of Rural Healthsheds lig

Updated on: February 18,2024

Study reveals persistent cancer disparities in Appalachian Kentucky

by Elizabeth Chapin,University of KentuckyCredit: Pixabay/CC0 Public DomainA recent University of Kentucky Markey Cancer Center study published inThe Journal of Rural Healthsheds lig

Updated on:February 18,2024

Study uncovers how B cells react to skin cancer

by King's College LondonSpatial transcriptomic coupled with high throughput intratumoral antibody repertoire analyses suggest an active but aberrant B cell response.aRepresentativ

Updated on: February 23,2024

Study uncovers how B cells react to skin cancer

by King's College LondonSpatial transcriptomic coupled with high throughput intratumoral antibody repertoire analyses suggest an active but aberrant B cell response.aRepresentativ

Updated on:February 23,2024

Molecular change to immunotherapy antibody could accelerate immune response to cancer

byWeizmann Institute of ScienceTissue sample of a particularly aggressive skin cancer reveals immune cells (yellow) that express on their surfaces a “brake pedal” receptor called FcgIIb (purple)

Updated on: January 02,2024

Molecular change to immunotherapy antibody could accelerate immune response to cancer

byWeizmann Institute of ScienceTissue sample of a particularly aggressive skin cancer reveals immune cells (yellow) that express on their surfaces a “brake pedal” receptor called FcgIIb (purple)

Updated on:January 02,2024

Study discovers tumor monocyte content predicts immunochemotherapy outcomes for esophageal cancer

by Ludwig Institute for Cancer ResearchGraphical Abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.06.006A Ludwig Cancer Research study has discovered that the presence of

Updated on: February 01,2024

Study discovers tumor monocyte content predicts immunochemotherapy outcomes for esophageal cancer

by Ludwig Institute for Cancer ResearchGraphical Abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.06.006A Ludwig Cancer Research study has discovered that the presence of

Updated on:February 01,2024

New study shows recently diagnosed adult cancer survivors at higher risk for bone fractures

byAmerican Cancer SocietyAdult cancer survivors at increased risk for bone fractures. Credit: American Cancer SocietyAdult cancer survivors, particularly those diagnosed within five years and/or

Updated on: January 12,2024

New study shows recently diagnosed adult cancer survivors at higher risk for bone fractures

byAmerican Cancer SocietyAdult cancer survivors at increased risk for bone fractures. Credit: American Cancer SocietyAdult cancer survivors, particularly those diagnosed within five years and/or

Updated on:January 12,2024

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l

Updated on: January 30,2024

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l

Updated on:January 30,2024

Researchers uncover aberrant natural killer cell subtype

by University of Science and Technology of ChinaGraphical Abstract. Credit:Cell(2023). DOI: 10.1016/j.cell.2023.07.034A team led by Prof. Tian Zhigang and Prof. Peng Hui from the Universit

Updated on: June 15,2024

Researchers uncover aberrant natural killer cell subtype

by University of Science and Technology of ChinaGraphical Abstract. Credit:Cell(2023). DOI: 10.1016/j.cell.2023.07.034A team led by Prof. Tian Zhigang and Prof. Peng Hui from the Universit

Updated on:June 15,2024

New method eradicates deadly brain tumors by 'starving' them of energy source

byTel Aviv UniversityDr. Lior Mayo and students. Credit: Tel Aviv UniversityA groundbreaking study at Tel Aviv University effectively eradicated glioblastoma, a highly lethal type of brain cance

Updated on: January 13,2024

New method eradicates deadly brain tumors by 'starving' them of energy source

byTel Aviv UniversityDr. Lior Mayo and students. Credit: Tel Aviv UniversityA groundbreaking study at Tel Aviv University effectively eradicated glioblastoma, a highly lethal type of brain cance

Updated on:January 13,2024

Experts boost activity of potential therapeutic target in triple-negative breast cancer

by Diana Yates,University of Illinois at Urbana-ChampaignCredit: Unsplash/CC0 Public DomainLess than 20% of diagnosed breast cancers are designated "triple-negative," lacking three typ

Updated on: January 22,2024

Experts boost activity of potential therapeutic target in triple-negative breast cancer

by Diana Yates,University of Illinois at Urbana-ChampaignCredit: Unsplash/CC0 Public DomainLess than 20% of diagnosed breast cancers are designated "triple-negative," lacking three typ

Updated on:January 22,2024

Researchers describe a molecular strategy that helps prevent tumour formation in mice

by The Spanish National Cancer Research CentreCredit: CNIOThe body's process for manufacturing fatty acids is regulated by the enzyme FASN. In normal cells, this is not a very active process—

Updated on: June 08,2024

Researchers describe a molecular strategy that helps prevent tumour formation in mice

by The Spanish National Cancer Research CentreCredit: CNIOThe body's process for manufacturing fatty acids is regulated by the enzyme FASN. In normal cells, this is not a very active process—

Updated on:June 08,2024